Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

Strong infectivity enables coronavirus disease 2019 (COVID-19) to rage throughout the world. Moreover, the lack of drugs with definite therapeutic effects further aggravates the spread of the pandemic. Remdesivir is one of the most promising anti-severe acute respiratory syndrome coronavirus 2 (SARS...

Full description

Bibliographic Details
Main Authors: Jingjing Li, Kai Zhang, Di Wu, Lianjie Ren, Xinyu Chu, Chao Qin, Xiaopeng Han, Taijun Hang, Yungen Xu, Lei Yang, Lifang Yin
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
COVID-19
Remdesivir
Pulmonary delivery
Liposomal aerosol
Nucleotide triphosphate
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087621000866

Internet

http://www.sciencedirect.com/science/article/pii/S1818087621000866

Similar Items